Sex-Specific Safety Signals of Finerenone Versus Spironolactone: Insights From the FDA Adverse Event Reporting System.
Authors: Singla A, Singh G, Kaur G, Luthra S, Lodha C, Malik MS, Kalsoom S, Alo MS, Ali SS, Zulqarnain M
Journal: Cureus
depression treatment
mental health
open access